Vishay Precision Group, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Vishay Precision Group, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	225	254	300	284	270	318	363	355	307	307
Cost of revenue	142	156	179	172	166	193	213	205	181	188
Gross profit	82.8	98.3	121	112	104	125	150	150	126	119
Research and development	11.1	11.7	11.8	12.1	12.6	17.2	19.8	20.4	20	20.8
Selling, general and administrative	68.4	73.8	80.9	79.6	78.3	95.3	104	107	108	110
General and administrative								33.5	32.3	35.4
Operating income	11.3	22.5	37.2	28.6	22.7	27.4	43.8	42	16.9	13.8
Interest expense	1.49	1.84	1.74	1.51	1.37	1.23	2.27	3.97	2.51	1.94
Interest income	0.18	0.17	0.51	0.62	0.25	0.25	0.4	1.65	1.67	1.7
Other non-operating income	-1.66	-1.93	-3.23	-2.21	-4.35	-1.46	1.29	-3.52	0.7	-5.05
Pre-tax income	9.61	20.6	34	26.4	18.3	25.9	45.1	38.4	17.6	8.8
Income tax	3.2	6.17	10.3	4.15	7.51	5.47	8.54	12.4	7.73	3.45
Net income to minority interests	0	0.05	-0	0.11	0.01	0.22	0.49	0.3	-0.08	0.05
Net income	6.4	14.3	23.6	22.2	10.8	20.2	36.1	25.7	9.91	5.29
EBITDA	22.4	33.1	47.9	40.4	35.2	42.4	59.2	57.5	32.7	29.8
EPS, basic	0.49	1.08	1.76	1.64	0.80	1.49	2.65	1.89	0.74	0.40
EPS, diluted	0.48	1.07	1.75	1.63	0.79	1.48	2.63	1.88	0.74	0.40
Shares, basic (weighted)	13.2	13.3	13.4	13.5	13.6	13.6	13.6	13.6	13.4	13.3
Shares, diluted (weighted)	13.4	13.5	13.5	13.6	13.6	13.7	13.7	13.7	13.4	13.3

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	58.5	74.3	90.2	86.9	98.4	84.3	88.6	84	79.3	87.4
Short-term investments							0		0	0
Receivables	34.3	46.8	53.2	43.2	45.3	58.3	60.1	56.4	51.2	56.3
Inventory	56.3	59.9	62.2	66.9	62.3	76.4	84.7	88.1	84.2	82.8
Other current assets	6.83	10.3	9.31	15.6	15.8	15.9	18.5	14.5	17.1	20.4
Total current assets	156	191	215	213	222	235	252	243	237	247
Property, plant and equipment	55.3	55.7	59.4	61.3	75	81.2	87.1	90.6	79.5	76.1
Lease right-of-use assets				8.69	21.8	27.8	24.3	27	24.3	22.9
Goodwill	18.7	19.2	16.1	35	31.1	45.8	45.5	45.7	46.8	47.4
Intangible assets	21.6	20.5	17.7	34.2	32	52.4	48.2	44.6	41.8	38.2
Other non-current assets	19	19.9	18.3	18.7	20.1	19.7	19.7	20.5	21.5	24.4
Total assets	271	307	326	370	402	462	477	472	451	456
Accounts payable	8.26	13.7	11.5	8.87	10.5	14.9	13.8	11.7	9.89	10.5
Accrued liabilities	13.3	16	17	16.1	13.8	17.6	20.3	22.4	19.7	19.6
Deferred revenue										0.61
Short-term debt	2.62	3.88	4.65	44.5	0.02	0		0
Total current liabilities	36.9	51.9	54.8	88.9	47.5	64.6	64.3	61.6	53	55.3
Long-term debt	33.5	28.5	22.4	0.02	40.6	60.7	60.8	31.9	31.4	20.6
Lease liabilities				5.81	19.5	25.1	20	22.6	19.9	19.5
Other non-current liabilities	13.1	14.1	13.5	14.8	16.3	16.3	13.1	14.8	14.2	14.2
Total liabilities	99	113	108	129	144	185	170	142	129	120
Total debt	36.2	32.4	27.1	44.5	40.6	60.7	60.8	31.9	31.4	20.6
Paid-in capital	190	193	197	197	198	199	201	203	203	204
Retained earnings	28.7	43.1	66.6	89.3	100	120	156	182	192	197
Treasury stock	-8.77	-8.77	-8.77	-8.77	-8.77	-8.77	-11.5	-17.5	-25.3	-25.3
Other comprehensive income	-40.3	-35.5	-37.5	-37.7	-32.7	-35	-40.9	-38.9	-48.9	-41.4
Shareholders' equity	171	193	218	241	258	277	307	330	322	336
Minority interests	0.17	0.15	0.04	0.39	0.03	-0.06	-0.03	0.08	-0.11	-0.14
Total equity	172	193	218	242	258	277	307	330	322	336
Total liabilities and equity	271	307	326	370	402	462	477	472	451	456
Shares outstanding	12.2	12.3	12.4	12.5	12.6	12.6	12.5	12.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	6.41	14.4	23.6	22.3	10.8	20.4	36.6	26	9.83	5.34
Depreciation and amortization	11.1	10.6	10.6	11.8	12.5	15	15.4	15.6	15.8	15.9
Stock-based compensation	0.04	1.5	1.8	1.34	1.39	2.24	2.44	2.29	0.97	1.79
Deferred income tax	0.3	1.89	1.01	-2.56	1.15	-3.26	-2.04	-0.16	0.07	-1.93
Change in receivables	1.32	-10.5	-7.76	11.4	-0.75	-8.04	-4.78	3.79	3.24	-3.14
Change in inventory	-1.97	-4.31	-5.1	-0.62	2.99	-8.63	-11.9	-4.9	2.14	0.97
Change in payables								-2.66	-0.42	0.4
Cash from operations	11.5	22.7	35.4	30.9	35.3	33.5	33	45.9	19.8	14.4
Capital expenditures	-10.4	-10.1	-13.2	-10.5	-22.9	-17.1	-21.3	-15.2	-9.16	-8.03
Acquisitions	-10.6	0	0	-40.5	0.16	-47.2	0	0	-4.41	0
Purchases of investments						0	0	-1	0	0
Cash from investing	-16.8	-6.42	-14.4	-51.1	-21.8	-64	-20.8	-15.1	-12.9	2.9
Debt issued	0	0
Debt repaid	0	0				-0.02	0	0
Share buybacks	0	0			0	0	-2.74	-5.92	-7.82	0
Cash from financing	2.77	-3.01	-3.51	16.5	-5.03	18.8	-3.63	-35.9	-9.4	-11.4
Exchange rate effect	-1.61	2.54	-1.61	0.41	3.06	-2.41	-4.33	0.55	-2.21
Net change in cash	-4.19	15.8	15.9	-3.25	11.5	-14.1	4.23	-4.6	-4.69	8.09
Free cash flow	1.08	12.6	22.1	20.4	12.4	16.5	11.7	30.7	10.7	6.35
Interest paid	1.3	1.7	1.6	1.4	1.3	1.2	2.3	4	2.5
Income taxes paid	3.9	4.1	7.3	11.1	4.3	7.7	10.8	10.9	14.5	8.02

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $71.63 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	38.7%	Gross profit / revenue.
Operating margin	3.4%	Operating income / revenue.
EBITDA margin	8.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.2%	Pre-tax income / revenue.
Net margin	1.2%	Net income / revenue.
FCF margin	-2.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	0.9%	Cash from operations / revenue.
Effective tax rate	44.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	1.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.9%	Net income / average total assets.
Return on invested capital (ROIC)	2.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	6.7%	Research and development expense / revenue.
SG&A / revenue	36.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.1%	Capital expenditures / revenue.
D&A / revenue	5.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-5.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-4.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-7.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-17.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-31.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-9.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-8.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-20.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-3.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-46.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-47.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-13.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-45.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-46.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-12.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-27.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-24.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-16.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-40.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-18.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-12.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	4.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.15x	Current assets / current liabilities.
Quick ratio	2.35x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.29x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.05x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	3.5%	Total debt / total assets.
Liabilities / assets	26.2%	Total liabilities / total assets.
Net debt	-$60.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-2.18x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	7.44x	Operating income / interest expense.
Working capital	$185.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	18.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$249.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.73x	Revenue / average total assets.
Fixed asset turnover	4.38x	Revenue / average property, plant and equipment.
Inventory turnover	2.39x	Cost of revenue / average inventory.
Days inventory	153 days	365 x average inventory / cost of revenue.
Receivables turnover	5.28x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
Days payables	21 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	201 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-189.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	362.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$296.62	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$24,687.00	Revenue / diluted weighted shares.
FCF per share	-$561.31	Free cash flow / diluted weighted shares.
Operating cash flow per share	$213.82	Cash from operations / diluted weighted shares.
Book value per share	$25,000.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$18,749.00	Tangible book value / shares outstanding.
Cash per share	$5,688.00	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$954.1M	Share price x shares outstanding.
Enterprise value	$894.1M	Market cap + total debt - cash - short-term investments.
P/E	242x	Market cap / net income. Only when net income is positive.
P/S	2.90x	Market cap / revenue.
P/B	2.87x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.82x	Market cap / tangible book value, when positive.
P/OCF	335x	Market cap / cash from operations, when positive.
EV/Sales	2.72x	Enterprise value / revenue.
EV/EBIT	79.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	32.4x	Enterprise value / EBITDA, when both are positive.
FCF yield	-0.8%	Free cash flow / market cap.
Earnings yield	0.4%	Net income / market cap (the inverse of P/E).

What was Vishay Precision Group, Inc.'s revenue in fiscal 2025?

Vishay Precision Group, Inc. reported revenue of $307.2M for fiscal 2025, 0.2% higher than the year before.

Was Vishay Precision Group, Inc. profitable in fiscal 2025?

Yes. Net income was $5.3M, a net margin of 1.7%.

How much free cash flow did Vishay Precision Group, Inc. generate in fiscal 2025?

Cash from operations of $14.4M minus capital expenditures of $8.0M left free cash flow of $6.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Vishay Precision Group, Inc.